Effectiveness of sectral (M & B 17803A) as a beta-blocking agent in man.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000787:Angina Pectoris / Q000188:drug therapy*; D000813:Anilides / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D004983:Ethanolamines / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008875:Middle Aged; D010919:Placebos; D011437:Propylamines / Q000627:therapeutic use; D014636:Valsalva Maneuver
D000319:Adrenergic beta-Antagonists; D000813:Anilides; D004983:Ethanolamines; D010919:Placebos; D011437:Propylamines; D007545:Isoproterenol